These CD163+ TAM metrics as well as the median of the cancer cell-to-CD163+ TAM NND distribution remained significant predictors of PFS in multivariable Cox models adjusted for significant clinicopathological prognostic factors (Table 3). The gene discussed is CD163; the disease is cancer.